DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Expenditure | ₹6,391 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹5,079 Cr | ₹4,108 Cr |
What is the latest Total Expenditure of DIVIS LABORATORIES ?
Year | Total Expenditure |
---|---|
Mar2025 | ₹6,391 Cr |
Mar2024 | ₹5,639 Cr |
Mar2023 | ₹5,398 Cr |
Mar2022 | ₹5,079 Cr |
Mar2021 | ₹4,108 Cr |
How is Total Expenditure of DIVIS LABORATORIES Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2025 | ₹6,391 Cr | 13.34 | |
Mar2024 | ₹5,639 Cr | 4.46 | |
Mar2023 | ₹5,398 Cr | 6.29 | |
Mar2022 | ₹5,079 Cr | 23.62 | |
Mar2021 | ₹4,108 Cr | - |
Compare Total Expenditure of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹180,152.4 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
MANKIND PHARMA | ₹108,985.0 Cr | 2.4% | 12.2% | 22.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.7% |
3.8% |
49.3% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses